[18F]RPS-544

N/A

Report date: 2025/11/21 17:15:28
NME

Base Information

Drug Name[18F]RPS-544
Drug Alias Name[18F]RPS-54418-F-RPS-544
ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentSmall molecules +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWeill Cornell Medicine
China Registration ClassN/A

Develop Information

Active CompaniesWeill Cornell Medicine
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A